(Reuters) – The United States government has set a benchmark for the price of the COVID-19 vaccine in a $ 2 billion deal announced Wednesday with Pfizer Inc (PFE.N) and the German biotechnology BioNTech SE (22UAy.F) which will likely pressure other manufacturers to set similar prices, industry analysts told Reuters. …
Read More »
NEW YORK (Reuters) – As the global race for a COVID-19 vaccine accelerates, Reuters invited a group of healthcare experts to answer questions as part of our #AskReuters Twitter chat series. FILE PHOTO: Professor Gottfried Kremsner injects a coronavirus disease vaccine (COVID-19) from the German biotech company CureVac into a …
Read More »
FILE PHOTO: Mike Ryan, Executive Director of the World Health Organization (WHO) attends a press conference on the Ebola outbreak in the Democratic Republic of the Congo at the United Nations in Geneva, Switzerland, May 3, 2019 REUTERS / Denis Balibouse GENEVA / ZURICH (Reuters) – Researchers are making “good …
Read More »
NEW DELHI (Reuters) – United States Secretary of State Mike Pompeo urged India on Wednesday to focus on national supply chains and reduce its dependence on China for telecommunications and medical supplies as Washington ties with Beijing they deteriorate dramatically. United States Secretary of State Mike Pompeo is seen during …
Read More »
CHICAGO (Reuters) – Early data from trials of three potential COVID-19 vaccines released Monday, including a closely watched Oxford University candidate, raised confidence that a vaccine can train the immune system to recognize and combat the new coronavirus without serious side effects It is still unclear whether any of these …
Read More »